Plasmapheresis, CMV Hyperimmune Globulin, and Anti-CD20 Allow ABO-Incompatible Renal Transplantation Without Splenectomy
Open Access
- 16 July 2004
- journal article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 4 (8), 1315-1322
- https://doi.org/10.1111/j.1600-6143.2004.00507.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patientsTransplantation, 2003
- Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximabTransplantation, 2003
- ABO-incompatible kidney transplantation using both A2 and non-A2 living donorsTransplantation, 2003
- The mechanisms of action of rituximab in the elimination of tumor cellsSeminars in Oncology, 2003
- Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresisTransplantation, 2002
- C4d staining of perioperative renal transplant biopsies1Transplantation, 2002
- ANTI-AB TITER CHANGES IN PATIENTS WITH ABO INCOMPATIBILITY AFTER LIVING RELATED KIDNEY TRANSPLANTATIONSTransplantation, 2000
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999
- LONG-TERM RESULTS OF ABO-INCOMPATIBLE LIVING KIDNEY TRANSPLANTATIONTransplantation, 1998
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976